Get 20% lifetime commission for referring investors to digrin.com
here.
Prelude Therapeutics Incorporated (PRLD) Financials
PRLD Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 189.4 million | 55.6 million |
| March 31, 2026 | 119.6 million | 59.5 million |
| Dec. 31, 2025 | 141.3 million | 72.7 million |
| Sept. 30, 2025 | 94.8 million | 36.2 million |
PRLD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -15.6 million | 2.0 million |
| March 31, 2026 | -21.7 million | 2.0 million |
| Dec. 31, 2025 | 23.1 million | 1.8 million |
| Sept. 30, 2025 | -19.1 million | 2.4 million |
PRLD Net Income
No data available :(
PRLD Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 151.8 million | 14.9 million | 14.9 million |
| March 31, 2026 | 81.6 million | - | 17.7 million |
| Dec. 31, 2025 | 103.2 million | - | 17.8 million |
| Sept. 30, 2025 | 55.0 million | - | 17.9 million |
PRLD Shares Outstanding
PRLD Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 16.1 million | 5.0 million | - |
| March 31, 2026 | - | 13.6 million | 4.8 million | -391000 |
| Dec. 31, 2025 | - | 18.0 million | 5.0 million | - |
| Sept. 30, 2025 | - | 21.7 million | 5.2 million | - |
PRLD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 5.7 million | - |
| March 31, 2026 | 4.6 million | 391000 |
| Dec. 31, 2025 | 5.6 million | 418000 |
| Sept. 30, 2025 | 6.5 million | 425000 |
PRLD
Price: $5.63
52 week price:
Earnings Per Share: -0.73 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 65500
Market Capitalization: 442.9 million